Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
2021 Meetings February 23â24, 2021 (virtual) The meeting covered topics related to new developments in the field including the following: regulatory updates related to regenerative medicine, recent progress in gene therapy, opportunities for decentralized clinical trials in regenerative medicine, and state-level policies around unproven stem cell offerings. The meeting also featured an educational session on the role of the immune system in regenerative medicine to help inform members as they developed the public workshop on this topic for late 2021. June 14â15, 2021 (virtual) In addition to updates from forum members, the meeting included updates from the National Academiesâ activities related to COVID-19 and organoids. The meeting included a session on expanding the training infrastructure to better support the regenerative medicine workforce and a session exploring stem cell offerings at academic medical centers, with the goal of better understanding the scope and context in which stem cells are being used for orthopedic applications. November 2â3, 2021 (virtual) Understanding the Role of the Immune November 10, 2021 (virtual) System in Improving Tissue Regeneration â At this meeting, members debriefed following the A Workshop public workshop, Understanding the Role of the Immune System in Improving Tissue Regeneration, and discussed next steps. In addition, the forum launched a strategic planning initiative that will continue into 2022 to chart the groupâs path forward for the next 3â5 years. 2021 Annual Report | 3
